LONDON (Sputnik) – The University of Oxford will test the efficacy of the COVID-19 vaccine it developed together with the UK-Swedish drugmaker AstraZeneca in children as young as six.
The first vaccinations are expected to take place later this month. A total of 240 children will be administered the vaccine. The trial is funded by the UK’s state-run National Institute for Health Research and AstraZeneca.
FILE – In this Wednesday, June 24, 2020 file photo, a volunteer receives an injection at the Chris Hani Baragwanath hospital in Soweto, Johannesburg.
Phase 2 trials will see 300 volunteers aged up to 17 injected with either the anti-coronavirus vaccine or a control shot against meningitis, which produces similar reactions, according to a press release.
Sourse: sputniknews.com
